Stocks
Clover Health Investments Financial Statements (CLOV) |
||||||||||
| Clover Health Investmentssmart-lab.ru | % | 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 08.08.2023 | 06.11.2023 | 12.03.2024 | 14.03.2024 | 07.05.2024 | 07.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 513.6 | 482.1 | 510.3 | 505.4 | 346.5 | 1 844 | |||
| Operating Income, bln rub | -28.8 | -41.5 | -65.7 | -65.7 | -22.7 | -195.5 | ||||
| EBITDA, bln rub | ? | -23.1 | -39.6 | -65.0 | -47.0 | -21.2 | -172.8 | |||
| Net profit, bln rub | ? | -28.8 | -41.5 | 0.000 | -70.5 | -19.2 | -131.1 | |||
| OCF, bln rub | ? | 53.2 | -18.8 | -69.8 | -229.3 | 25.9 | -291.9 | |||
| CAPEX, bln rub | ? | 0.354 | 0.243 | 0.000 | 0.264 | 0.445 | 0.952 | |||
| FCF, bln rub | ? | 52.8 | -19.0 | -69.8 | -229.0 | 25.5 | -292.4 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| OPEX, bln rub | 100.7 | 103.3 | 512.0 | 110.6 | 104.1 | 829.9 | ||||
| Cost of production, bln rub | 437.0 | 419.0 | 63.9 | 448.0 | 265.2 | 1 196 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 0.007 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Assets, bln rub | 1 258 | 1 060 | 570.7 | 570.7 | 671.8 | 671.8 | ||||
| Net Assets, bln rub | ? | 330.6 | 321.9 | 286.4 | 286.4 | 292.5 | 292.5 | |||
| Debt, bln rub | 5.35 | 4.96 | 0.000 | 4.66 | 4.34 | 4.34 | ||||
| Cash, bln rub | 520.6 | 517.1 | 417.3 | 242.7 | 343.1 | 343.1 | ||||
| Net debt, bln rub | -515.2 | -512.2 | -417.3 | -238.0 | -338.8 | -338.8 | ||||
| Ordinary share price, rub | 0.897 | 1.08 | 0.952 | 0.952 | 0.794 | 1.01 | ||||
| Number of ordinary shares, mln | 479.2 | 480.8 | 481.6 | 481.6 | 486.4 | 486.4 | ||||
| Market cap, bln rub | 430 | 519 | 459 | 459 | 386 | 491 | ||||
| EV, bln rub | ? | -85 | 7 | 41 | 221 | 47 | 152 | |||
| Book value, bln rub | 311 | 303 | 286 | 283 | 292 | 292 | ||||
| EPS, rub | ? | -0.06 | -0.09 | 0.00 | -0.15 | -0.04 | -0.27 | |||
| FCF/share, rub | 0.11 | -0.04 | -0.14 | -0.48 | 0.05 | -0.60 | ||||
| BV/share, rub | 0.65 | 0.63 | 0.59 | 0.59 | 0.60 | 0.60 | ||||
| EBITDA margin, % | ? | -4.49% | -8.21% | -12.7% | -9.29% | -6.12% | -9.37% | |||
| Net margin, % | ? | -5.61% | -8.60% | 0.00% | -13.9% | -5.53% | -7.11% | |||
| FCF yield, % | ? | 4.59% | -19.4% | 9.33% | -25.4% | -44.0% | -59.5% | |||
| ROE, % | ? | -72.4% | -63.5% | -49.9% | -74.5% | -54.7% | -44.8% | |||
| ROA, % | ? | -19.0% | -19.3% | -25.0% | -37.4% | -23.8% | -19.5% | |||
| P/E | ? | -1.80 | -2.54 | -3.21 | -2.15 | -2.41 | -3.75 | |||
| P/FCF | 21.8 | -5.16 | 10.7 | -3.94 | -2.28 | -1.68 | ||||
| P/S | ? | 0.15 | 0.21 | 0.23 | 0.23 | 0.21 | 0.27 | |||
| P/BV | ? | 1.38 | 1.72 | 1.60 | 1.62 | 1.32 | 1.68 | |||
| EV/EBITDA | ? | 0.31 | -0.03 | -0.21 | -1.21 | -0.36 | -0.88 | |||
| Debt/EBITDA | 1.87 | 2.12 | 2.09 | 1.31 | 2.59 | 1.96 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| CAPEX/Revenue, % | 0.07% | 0.05% | 0.00% | 0.05% | 0.13% | 0.05% | ||||
| Clover Health Investments shareholders | ||||||||||
